RxDoctor Payments Data

Tracy Merrell, DPM

Podiatrist · Murfreesboro, TNNPI 1275515223

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 445 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Smith+Nephew accounts for 80.5% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2021 at $2,849 and has fallen 67.1% since, to $936 in 2025.

$9,655in general payments, 2019–2025

Across 445 payments — averaging $21.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$8K
  • Osiris Therapeutics Inc.$342
  • Paratek Pharmaceuticals, Inc.$244
  • Organogenesis Inc.$234
  • Aroa Biosurgery Incorporated$105
  • Stryker$105
  • plus $858 from 21 others

What the payments were for

  • Food & beverage$9,640100%
  • Education$150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,655 in reported general payments places this provider in the 85th percentile of 105 podiatrist providers in Tennessee.

See all podiatrist providers in Tennessee

Medicare billing

Part B allowed, 2024
$98,760
Medicare patients
241
Services billed
1,200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate89$4,159
Linezolid44$2,383
Gabapentin33$1,249
Pregabalin24$1,189
Doxycycline Hyclate83$804
Ciprofloxacin Hcl48$474
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen78$414
Cephalexin33$355
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim46$331
Methylprednisolone31$188
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$170
Ketoconazole11$167
Clindamycin Hcl12$123
Mupirocin12$109
Fluconazole17$88

Paid to pharmacies, not to this prescriber.

Other podiatrist in Murfreesboro

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →